Selecting a randomization method for a multi-center clinical trial with stochastic recruitment considerations
Background The design of a multi-center randomized controlled trial (RCT) involves multiple considerations, such as the choice of the sample size, the number of centers and their geographic location, the strategy for recruitment of study participants, amongst others. There are plenty of methods to s...
Saved in:
Published in | BMC medical research methodology Vol. 24; no. 1; pp. 52 - 23 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
BioMed Central
28.02.2024
BioMed Central Ltd BMC |
Subjects | |
Online Access | Get full text |
ISSN | 1471-2288 1471-2288 |
DOI | 10.1186/s12874-023-02131-z |
Cover
Abstract | Background
The design of a multi-center randomized controlled trial (RCT) involves multiple considerations, such as the choice of the sample size, the number of centers and their geographic location, the strategy for recruitment of study participants, amongst others. There are plenty of methods to sequentially randomize patients in a multi-center RCT, with or without considering stratification factors. The goal of this paper is to perform a systematic assessment of such randomization methods for a multi-center 1:1 RCT assuming a competitive policy for the patient recruitment process.
Methods
We considered a Poisson-gamma model for the patient recruitment process with a uniform distribution of center activation times. We investigated 16 randomization methods (4 unstratified, 4 region-stratified, 4 center-stratified, 3 dynamic balancing randomization (DBR), and a complete randomization design) to sequentially randomize
n
=
500
patients. Statistical properties of the recruitment process and the randomization procedures were assessed using Monte Carlo simulations. The operating characteristics included time to complete recruitment, number of centers that recruited a given number of patients, several measures of treatment imbalance and estimation efficiency under a linear model for the response, the expected proportions of correct guesses under two different guessing strategies, and the expected proportion of deterministic assignments in the allocation sequence.
Results
Maximum tolerated imbalance (MTI) randomization methods such as big stick design, Ehrenfest urn design, and block urn design result in a better balance–randomness tradeoff than the conventional permuted block design (PBD) with or without stratification. Unstratified randomization, region-stratified randomization, and center-stratified randomization provide control of imbalance at a chosen level (trial, region, or center) but may fail to achieve balance at the other two levels. By contrast, DBR does a very good job controlling imbalance at all 3 levels while maintaining the randomized nature of treatment allocation. Adding more centers into the study helps accelerate the recruitment process but at the expense of increasing the number of centers that recruit very few (or no) patients—which may increase center-level imbalances for center-stratified and DBR procedures. Increasing the block size or the MTI threshold(s) may help obtain designs with improved randomness–balance tradeoff.
Conclusions
The choice of a randomization method is an important component of planning a multi-center RCT. Dynamic balancing randomization with carefully chosen MTI thresholds could be a very good strategy for trials with the competitive policy for patient recruitment. |
---|---|
AbstractList | The design of a multi-center randomized controlled trial (RCT) involves multiple considerations, such as the choice of the sample size, the number of centers and their geographic location, the strategy for recruitment of study participants, amongst others. There are plenty of methods to sequentially randomize patients in a multi-center RCT, with or without considering stratification factors. The goal of this paper is to perform a systematic assessment of such randomization methods for a multi-center 1:1 RCT assuming a competitive policy for the patient recruitment process.
We considered a Poisson-gamma model for the patient recruitment process with a uniform distribution of center activation times. We investigated 16 randomization methods (4 unstratified, 4 region-stratified, 4 center-stratified, 3 dynamic balancing randomization (DBR), and a complete randomization design) to sequentially randomize
patients. Statistical properties of the recruitment process and the randomization procedures were assessed using Monte Carlo simulations. The operating characteristics included time to complete recruitment, number of centers that recruited a given number of patients, several measures of treatment imbalance and estimation efficiency under a linear model for the response, the expected proportions of correct guesses under two different guessing strategies, and the expected proportion of deterministic assignments in the allocation sequence.
Maximum tolerated imbalance (MTI) randomization methods such as big stick design, Ehrenfest urn design, and block urn design result in a better balance-randomness tradeoff than the conventional permuted block design (PBD) with or without stratification. Unstratified randomization, region-stratified randomization, and center-stratified randomization provide control of imbalance at a chosen level (trial, region, or center) but may fail to achieve balance at the other two levels. By contrast, DBR does a very good job controlling imbalance at all 3 levels while maintaining the randomized nature of treatment allocation. Adding more centers into the study helps accelerate the recruitment process but at the expense of increasing the number of centers that recruit very few (or no) patients-which may increase center-level imbalances for center-stratified and DBR procedures. Increasing the block size or the MTI threshold(s) may help obtain designs with improved randomness-balance tradeoff.
The choice of a randomization method is an important component of planning a multi-center RCT. Dynamic balancing randomization with carefully chosen MTI thresholds could be a very good strategy for trials with the competitive policy for patient recruitment. Abstract Background The design of a multi-center randomized controlled trial (RCT) involves multiple considerations, such as the choice of the sample size, the number of centers and their geographic location, the strategy for recruitment of study participants, amongst others. There are plenty of methods to sequentially randomize patients in a multi-center RCT, with or without considering stratification factors. The goal of this paper is to perform a systematic assessment of such randomization methods for a multi-center 1:1 RCT assuming a competitive policy for the patient recruitment process. Methods We considered a Poisson-gamma model for the patient recruitment process with a uniform distribution of center activation times. We investigated 16 randomization methods (4 unstratified, 4 region-stratified, 4 center-stratified, 3 dynamic balancing randomization (DBR), and a complete randomization design) to sequentially randomize $$n=500$$ n = 500 patients. Statistical properties of the recruitment process and the randomization procedures were assessed using Monte Carlo simulations. The operating characteristics included time to complete recruitment, number of centers that recruited a given number of patients, several measures of treatment imbalance and estimation efficiency under a linear model for the response, the expected proportions of correct guesses under two different guessing strategies, and the expected proportion of deterministic assignments in the allocation sequence. Results Maximum tolerated imbalance (MTI) randomization methods such as big stick design, Ehrenfest urn design, and block urn design result in a better balance–randomness tradeoff than the conventional permuted block design (PBD) with or without stratification. Unstratified randomization, region-stratified randomization, and center-stratified randomization provide control of imbalance at a chosen level (trial, region, or center) but may fail to achieve balance at the other two levels. By contrast, DBR does a very good job controlling imbalance at all 3 levels while maintaining the randomized nature of treatment allocation. Adding more centers into the study helps accelerate the recruitment process but at the expense of increasing the number of centers that recruit very few (or no) patients—which may increase center-level imbalances for center-stratified and DBR procedures. Increasing the block size or the MTI threshold(s) may help obtain designs with improved randomness–balance tradeoff. Conclusions The choice of a randomization method is an important component of planning a multi-center RCT. Dynamic balancing randomization with carefully chosen MTI thresholds could be a very good strategy for trials with the competitive policy for patient recruitment. The design of a multi-center randomized controlled trial (RCT) involves multiple considerations, such as the choice of the sample size, the number of centers and their geographic location, the strategy for recruitment of study participants, amongst others. There are plenty of methods to sequentially randomize patients in a multi-center RCT, with or without considering stratification factors. The goal of this paper is to perform a systematic assessment of such randomization methods for a multi-center 1:1 RCT assuming a competitive policy for the patient recruitment process.BACKGROUNDThe design of a multi-center randomized controlled trial (RCT) involves multiple considerations, such as the choice of the sample size, the number of centers and their geographic location, the strategy for recruitment of study participants, amongst others. There are plenty of methods to sequentially randomize patients in a multi-center RCT, with or without considering stratification factors. The goal of this paper is to perform a systematic assessment of such randomization methods for a multi-center 1:1 RCT assuming a competitive policy for the patient recruitment process.We considered a Poisson-gamma model for the patient recruitment process with a uniform distribution of center activation times. We investigated 16 randomization methods (4 unstratified, 4 region-stratified, 4 center-stratified, 3 dynamic balancing randomization (DBR), and a complete randomization design) to sequentially randomize n = 500 patients. Statistical properties of the recruitment process and the randomization procedures were assessed using Monte Carlo simulations. The operating characteristics included time to complete recruitment, number of centers that recruited a given number of patients, several measures of treatment imbalance and estimation efficiency under a linear model for the response, the expected proportions of correct guesses under two different guessing strategies, and the expected proportion of deterministic assignments in the allocation sequence.METHODSWe considered a Poisson-gamma model for the patient recruitment process with a uniform distribution of center activation times. We investigated 16 randomization methods (4 unstratified, 4 region-stratified, 4 center-stratified, 3 dynamic balancing randomization (DBR), and a complete randomization design) to sequentially randomize n = 500 patients. Statistical properties of the recruitment process and the randomization procedures were assessed using Monte Carlo simulations. The operating characteristics included time to complete recruitment, number of centers that recruited a given number of patients, several measures of treatment imbalance and estimation efficiency under a linear model for the response, the expected proportions of correct guesses under two different guessing strategies, and the expected proportion of deterministic assignments in the allocation sequence.Maximum tolerated imbalance (MTI) randomization methods such as big stick design, Ehrenfest urn design, and block urn design result in a better balance-randomness tradeoff than the conventional permuted block design (PBD) with or without stratification. Unstratified randomization, region-stratified randomization, and center-stratified randomization provide control of imbalance at a chosen level (trial, region, or center) but may fail to achieve balance at the other two levels. By contrast, DBR does a very good job controlling imbalance at all 3 levels while maintaining the randomized nature of treatment allocation. Adding more centers into the study helps accelerate the recruitment process but at the expense of increasing the number of centers that recruit very few (or no) patients-which may increase center-level imbalances for center-stratified and DBR procedures. Increasing the block size or the MTI threshold(s) may help obtain designs with improved randomness-balance tradeoff.RESULTSMaximum tolerated imbalance (MTI) randomization methods such as big stick design, Ehrenfest urn design, and block urn design result in a better balance-randomness tradeoff than the conventional permuted block design (PBD) with or without stratification. Unstratified randomization, region-stratified randomization, and center-stratified randomization provide control of imbalance at a chosen level (trial, region, or center) but may fail to achieve balance at the other two levels. By contrast, DBR does a very good job controlling imbalance at all 3 levels while maintaining the randomized nature of treatment allocation. Adding more centers into the study helps accelerate the recruitment process but at the expense of increasing the number of centers that recruit very few (or no) patients-which may increase center-level imbalances for center-stratified and DBR procedures. Increasing the block size or the MTI threshold(s) may help obtain designs with improved randomness-balance tradeoff.The choice of a randomization method is an important component of planning a multi-center RCT. Dynamic balancing randomization with carefully chosen MTI thresholds could be a very good strategy for trials with the competitive policy for patient recruitment.CONCLUSIONSThe choice of a randomization method is an important component of planning a multi-center RCT. Dynamic balancing randomization with carefully chosen MTI thresholds could be a very good strategy for trials with the competitive policy for patient recruitment. Background: The design of a multi-center randomized controlled trial (RCT) involves multiple considerations, such as the choice of the sample size, the number of centers and their geographic location, the strategy for recruitment of study participants, amongst others. There are plenty of methods to sequentially randomize patients in a multi-center RCT, with or without considering stratification factors. The goal of this paper is to perform a systematic assessment of such randomization methods for a multi-center 1:1 RCT assuming a competitive policy for the patient recruitment process. Methods: We considered a Poisson-gamma model for the patient recruitment process with a uniform distribution of center activation times. We investigated 16 randomization methods (4 unstratified, 4 region-stratified, 4 center-stratified, 3 dynamic balancing randomization (DBR), and a complete randomization design) to sequentially randomize n=500 patients. Statistical properties of the recruitment process and the randomization procedures were assessed using Monte Carlo simulations. The operating characteristics included time to complete recruitment, number of centers that recruited a given number of patients, several measures of treatment imbalance and estimation efficiency under a linear model for the response, the expected proportions of correct guesses under two different guessing strategies, and the expected proportion of deterministic assignments in the allocation sequence. Results: Maximum tolerated imbalance (MTI) randomization methods such as big stick design, Ehrenfest urn design, and block urn design result in a better balance-randomness tradeoff than the conventional permuted block design (PBD) with or without stratification. Unstratified randomization, region-stratified randomization, and center-stratified randomization provide control of imbalance at a chosen level (trial, region, or center) but may fail to achieve balance at the other two levels. By contrast, DBR does a very good job controlling imbalance at all 3 levels while maintaining the randomized nature of treatment allocation. Adding more centers into the study helps accelerate the recruitment process but at the expense of increasing the number of centers that recruit very few (or no) patients-which may increase center-level imbalances for center-stratified and DBR procedures. Increasing the block size or the MTI threshold(s) may help obtain designs with improved randomness-balance tradeoff. Conclusions: The choice of a randomization method is an important component of planning a multi-center RCT. Dynamic balancing randomization with carefully chosen MTI thresholds could be a very good strategy for trials with the competitive policy for patient recruitment. Background The design of a multi-center randomized controlled trial (RCT) involves multiple considerations, such as the choice of the sample size, the number of centers and their geographic location, the strategy for recruitment of study participants, amongst others. There are plenty of methods to sequentially randomize patients in a multi-center RCT, with or without considering stratification factors. The goal of this paper is to perform a systematic assessment of such randomization methods for a multi-center 1:1 RCT assuming a competitive policy for the patient recruitment process. Methods We considered a Poisson-gamma model for the patient recruitment process with a uniform distribution of center activation times. We investigated 16 randomization methods (4 unstratified, 4 region-stratified, 4 center-stratified, 3 dynamic balancing randomization (DBR), and a complete randomization design) to sequentially randomize [formula omitted] patients. Statistical properties of the recruitment process and the randomization procedures were assessed using Monte Carlo simulations. The operating characteristics included time to complete recruitment, number of centers that recruited a given number of patients, several measures of treatment imbalance and estimation efficiency under a linear model for the response, the expected proportions of correct guesses under two different guessing strategies, and the expected proportion of deterministic assignments in the allocation sequence. Results Maximum tolerated imbalance (MTI) randomization methods such as big stick design, Ehrenfest urn design, and block urn design result in a better balance-randomness tradeoff than the conventional permuted block design (PBD) with or without stratification. Unstratified randomization, region-stratified randomization, and center-stratified randomization provide control of imbalance at a chosen level (trial, region, or center) but may fail to achieve balance at the other two levels. By contrast, DBR does a very good job controlling imbalance at all 3 levels while maintaining the randomized nature of treatment allocation. Adding more centers into the study helps accelerate the recruitment process but at the expense of increasing the number of centers that recruit very few (or no) patients--which may increase center-level imbalances for center-stratified and DBR procedures. Increasing the block size or the MTI threshold(s) may help obtain designs with improved randomness-balance tradeoff. Conclusions The choice of a randomization method is an important component of planning a multi-center RCT. Dynamic balancing randomization with carefully chosen MTI thresholds could be a very good strategy for trials with the competitive policy for patient recruitment. Keywords: Multi-center clinical trial, Maximum tolerated imbalance, Allocation randomness, Poisson-gamma model, Recruitment time Background The design of a multi-center randomized controlled trial (RCT) involves multiple considerations, such as the choice of the sample size, the number of centers and their geographic location, the strategy for recruitment of study participants, amongst others. There are plenty of methods to sequentially randomize patients in a multi-center RCT, with or without considering stratification factors. The goal of this paper is to perform a systematic assessment of such randomization methods for a multi-center 1:1 RCT assuming a competitive policy for the patient recruitment process. Methods We considered a Poisson-gamma model for the patient recruitment process with a uniform distribution of center activation times. We investigated 16 randomization methods (4 unstratified, 4 region-stratified, 4 center-stratified, 3 dynamic balancing randomization (DBR), and a complete randomization design) to sequentially randomize n = 500 patients. Statistical properties of the recruitment process and the randomization procedures were assessed using Monte Carlo simulations. The operating characteristics included time to complete recruitment, number of centers that recruited a given number of patients, several measures of treatment imbalance and estimation efficiency under a linear model for the response, the expected proportions of correct guesses under two different guessing strategies, and the expected proportion of deterministic assignments in the allocation sequence. Results Maximum tolerated imbalance (MTI) randomization methods such as big stick design, Ehrenfest urn design, and block urn design result in a better balance–randomness tradeoff than the conventional permuted block design (PBD) with or without stratification. Unstratified randomization, region-stratified randomization, and center-stratified randomization provide control of imbalance at a chosen level (trial, region, or center) but may fail to achieve balance at the other two levels. By contrast, DBR does a very good job controlling imbalance at all 3 levels while maintaining the randomized nature of treatment allocation. Adding more centers into the study helps accelerate the recruitment process but at the expense of increasing the number of centers that recruit very few (or no) patients—which may increase center-level imbalances for center-stratified and DBR procedures. Increasing the block size or the MTI threshold(s) may help obtain designs with improved randomness–balance tradeoff. Conclusions The choice of a randomization method is an important component of planning a multi-center RCT. Dynamic balancing randomization with carefully chosen MTI thresholds could be a very good strategy for trials with the competitive policy for patient recruitment. The design of a multi-center randomized controlled trial (RCT) involves multiple considerations, such as the choice of the sample size, the number of centers and their geographic location, the strategy for recruitment of study participants, amongst others. There are plenty of methods to sequentially randomize patients in a multi-center RCT, with or without considering stratification factors. The goal of this paper is to perform a systematic assessment of such randomization methods for a multi-center 1:1 RCT assuming a competitive policy for the patient recruitment process. We considered a Poisson-gamma model for the patient recruitment process with a uniform distribution of center activation times. We investigated 16 randomization methods (4 unstratified, 4 region-stratified, 4 center-stratified, 3 dynamic balancing randomization (DBR), and a complete randomization design) to sequentially randomize [formula omitted] patients. Statistical properties of the recruitment process and the randomization procedures were assessed using Monte Carlo simulations. The operating characteristics included time to complete recruitment, number of centers that recruited a given number of patients, several measures of treatment imbalance and estimation efficiency under a linear model for the response, the expected proportions of correct guesses under two different guessing strategies, and the expected proportion of deterministic assignments in the allocation sequence. Maximum tolerated imbalance (MTI) randomization methods such as big stick design, Ehrenfest urn design, and block urn design result in a better balance-randomness tradeoff than the conventional permuted block design (PBD) with or without stratification. Unstratified randomization, region-stratified randomization, and center-stratified randomization provide control of imbalance at a chosen level (trial, region, or center) but may fail to achieve balance at the other two levels. By contrast, DBR does a very good job controlling imbalance at all 3 levels while maintaining the randomized nature of treatment allocation. Adding more centers into the study helps accelerate the recruitment process but at the expense of increasing the number of centers that recruit very few (or no) patients--which may increase center-level imbalances for center-stratified and DBR procedures. Increasing the block size or the MTI threshold(s) may help obtain designs with improved randomness-balance tradeoff. The choice of a randomization method is an important component of planning a multi-center RCT. Dynamic balancing randomization with carefully chosen MTI thresholds could be a very good strategy for trials with the competitive policy for patient recruitment. BackgroundThe design of a multi-center randomized controlled trial (RCT) involves multiple considerations, such as the choice of the sample size, the number of centers and their geographic location, the strategy for recruitment of study participants, amongst others. There are plenty of methods to sequentially randomize patients in a multi-center RCT, with or without considering stratification factors. The goal of this paper is to perform a systematic assessment of such randomization methods for a multi-center 1:1 RCT assuming a competitive policy for the patient recruitment process.MethodsWe considered a Poisson-gamma model for the patient recruitment process with a uniform distribution of center activation times. We investigated 16 randomization methods (4 unstratified, 4 region-stratified, 4 center-stratified, 3 dynamic balancing randomization (DBR), and a complete randomization design) to sequentially randomize \(n=500\) patients. Statistical properties of the recruitment process and the randomization procedures were assessed using Monte Carlo simulations. The operating characteristics included time to complete recruitment, number of centers that recruited a given number of patients, several measures of treatment imbalance and estimation efficiency under a linear model for the response, the expected proportions of correct guesses under two different guessing strategies, and the expected proportion of deterministic assignments in the allocation sequence.ResultsMaximum tolerated imbalance (MTI) randomization methods such as big stick design, Ehrenfest urn design, and block urn design result in a better balance–randomness tradeoff than the conventional permuted block design (PBD) with or without stratification. Unstratified randomization, region-stratified randomization, and center-stratified randomization provide control of imbalance at a chosen level (trial, region, or center) but may fail to achieve balance at the other two levels. By contrast, DBR does a very good job controlling imbalance at all 3 levels while maintaining the randomized nature of treatment allocation. Adding more centers into the study helps accelerate the recruitment process but at the expense of increasing the number of centers that recruit very few (or no) patients—which may increase center-level imbalances for center-stratified and DBR procedures. Increasing the block size or the MTI threshold(s) may help obtain designs with improved randomness–balance tradeoff.ConclusionsThe choice of a randomization method is an important component of planning a multi-center RCT. Dynamic balancing randomization with carefully chosen MTI thresholds could be a very good strategy for trials with the competitive policy for patient recruitment. |
ArticleNumber | 52 |
Audience | Academic |
Author | Kuznetsova, Olga M. Carter, Kerstine Ryeznik, Yevgen Anisimov, Volodymyr Knight, Ruth Drescher, Sonja Zhao, Wenle Sverdlov, Oleksandr |
Author_xml | – sequence: 1 givenname: Oleksandr orcidid: 0000-0002-1626-2588 surname: Sverdlov fullname: Sverdlov, Oleksandr email: alex.sverdlov@novartis.com organization: Novartis Pharmaceuticals Corporation – sequence: 2 givenname: Yevgen orcidid: 0000-0003-2997-8566 surname: Ryeznik fullname: Ryeznik, Yevgen organization: Department of Pharmacy, Uppsala University – sequence: 3 givenname: Volodymyr orcidid: 0000-0003-1230-1794 surname: Anisimov fullname: Anisimov, Volodymyr organization: Amgen Ltd – sequence: 4 givenname: Olga M. orcidid: 0000-0002-7037-3641 surname: Kuznetsova fullname: Kuznetsova, Olga M. organization: Merck & Co., Inc – sequence: 5 givenname: Ruth orcidid: 0000-0001-6810-2845 surname: Knight fullname: Knight, Ruth organization: Liverpool Clinical Trials Centre, University of Liverpool – sequence: 6 givenname: Kerstine orcidid: 0009-0004-6144-2344 surname: Carter fullname: Carter, Kerstine organization: Boehringer-Ingelheim Pharmaceuticals Inc – sequence: 7 givenname: Sonja surname: Drescher fullname: Drescher, Sonja organization: Boehringer-Ingelheim Pharma GmbH & Co. KG – sequence: 8 givenname: Wenle surname: Zhao fullname: Zhao, Wenle organization: Medical University of South Carolina |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38418968$$D View this record in MEDLINE/PubMed https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-525900$$DView record from Swedish Publication Index |
BookMark | eNp9kstu1DAUhiNURNuBF2CBIrFhQUp8ieOs0KgUqFSJBZet5Zw4Mx4ldrEdKubpe-ZC26lQFSWO7O__z8XnNDty3pkse03KM0Kk-BAJlTUvSsrwJYwU62fZCeE1KSiV8ujB_3F2GuOqLEktmXiRHTPJiWyEPMnG72YwkKxb5DoP2nV-tGudrHf5aNLSd3nvAx6N05BsAcYlE3IYrLOghzwFi98bm5Z5TB6WOiYLeTAQJptGhHPwLtrOhK1lfJk97_UQzav9Ost-fr74cf61uPr25fJ8flWA4FUqSMtbrqGqQVai7WtacdaVjEPfNoS0GqAlHRUGJO90reu263rSawlgmla0hM2yy51v5_VKXQc76vBXeW3VdsOHhdIBUx2MEg3jdSsbziVGpVpWTcMYsJ4T2usK0Ov9zivemOupPXD7ZH_Nt27TpCpaNWWJ-Mcdjuxouk3Hgh4OVIcnzi7Vwv9RpET5Jvgse7d3CP73ZGJSo41ghkE746eoKObHBeWEI_r2EbryU3DYWqQqIUWFOd1TC40FW9d7DAwbUzWvJaebkgVSZ_-h8OnMaPEaTW9x_0Dw5mGldyX-Gy4E6A6A4GMMpr9DSKk2E6x2E6xwgtV2gtUaRfKRCGzaTg-mY4enpWx_UxjHLUy478YTqlu2vgeq |
CitedBy_id | crossref_primary_10_1186_s12874_024_02340_0 crossref_primary_10_1002_ksa_12535 |
Cites_doi | 10.1002/9780471462422.eoct301 10.1002/sim.6266 10.1002/sim.4495 10.1080/03610928308828586 10.1002/(SICI)1097-0258(19990730)18:14<1741::AID-SIM210>3.0.CO;2-F 10.1214/08-STS269 10.1002/(SICI)1097-0258(19980815/30)17:15/16<1767::AID-SIM978>3.0.CO;2-H 10.1111/biom.13447 10.1186/s12874-017-0428-z 10.1002/sim.2956 10.1002/sim.3068 10.1007/978-3-7908-2410-0_1 10.1016/j.cct.2011.08.004 10.1214/aoms/1177706973 10.1080/03610926.2022.2152286 10.1080/03610926.2011.581189 10.1002/sim.2421 10.1007/978-0-8176-4542-7_25 10.1016/j.cct/2010.05.002 10.1007/978-3-7908-1952-6_1 10.1007/978-3-030-48555-9 10.1016/j.cct.2015.11.008 10.1056/NEJM197607082950204 10.1016/j.cct.2021.106450 10.1239/aap/1013540242 10.1002/(SICI)1097-0258(19980815/30)17:15/16<1753::AID-SIM977>3.0.CO;2-X 10.1002/cpt1974155443 10.1186/1471-2288-11-21 10.1002/(SICI)1097-0258(19980815/30)17:15/16<1779::AID-SIM979>3.0.CO;2-7 10.1002/pst.412 10.1002/sim.4780122410 10.1002/sim.7817 10.1002/sim.5667 10.1186/s12874-021-01303-z 10.1002/sim.7206 10.2307/2529712 10.1016/0197-2456(88)90046-3 10.1016/0197-2456(88)90050-5 10.1186/1471-2288-10-63 10.1002/sim.8160 10.1016/j.cct.2015.07.010 10.1016/0021-9681(74)90015-0 10.1177/009286150303700305 10.1016/0197-2456(88)90047-5 10.1016/j.cct.2005.09.002 10.3414/me0538 10.1007/978-3-031-17820-7_23 10.1016/0197-2456(93)90013-4 10.1016/j.cct.2015.01.013 |
ContentType | Journal Article |
Copyright | The Author(s) 2024 2024. The Author(s). COPYRIGHT 2024 BioMed Central Ltd. 2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: The Author(s) 2024 – notice: 2024. The Author(s). – notice: COPYRIGHT 2024 BioMed Central Ltd. – notice: 2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 5PM ACNBI ADTPV AOWAS D8T DF2 ZZAVC DOA |
DOI | 10.1186/s12874-023-02131-z |
DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) SWEPUB Uppsala universitet full text SwePub SwePub Articles SWEPUB Freely available online SWEPUB Uppsala universitet SwePub Articles full text DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1471-2288 |
EndPage | 23 |
ExternalDocumentID | oai_doaj_org_article_69347b89448b4b2a859933c3f412fa5c oai_DiVA_org_uu_525900 PMC10900599 A784285996 38418968 10_1186_s12874_023_02131_z |
Genre | Randomized Controlled Trial Multicenter Study Journal Article |
GeographicLocations | United States |
GeographicLocations_xml | – name: United States |
GroupedDBID | --- 0R~ 23N 2WC 53G 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABDBF ABUWG ACGFO ACGFS ACIHN ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK IAO IHR INH INR ITC KQ8 M1P M48 MK0 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB AAYXX ALIPV CITATION CGR CUY CVF ECM EIF NPM PMFND 3V. 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI 7X8 5PM 2VQ 4.4 ACNBI ADTPV AHSBF AOWAS C1A D8T DF2 EJD H13 HYE IPNFZ RIG ZZAVC |
ID | FETCH-LOGICAL-c645t-1b4b4ac57c856bf72543d034cfb911baccb1d26ec84da7a7bddf1fa8cce9b6b13 |
IEDL.DBID | M48 |
ISSN | 1471-2288 |
IngestDate | Wed Aug 27 01:26:43 EDT 2025 Tue Sep 09 23:24:53 EDT 2025 Thu Aug 21 18:35:02 EDT 2025 Fri Sep 05 09:05:38 EDT 2025 Sat Jul 26 00:15:39 EDT 2025 Tue Jun 17 22:16:05 EDT 2025 Tue Jun 10 21:12:45 EDT 2025 Wed Jul 30 01:47:43 EDT 2025 Thu Apr 24 23:01:23 EDT 2025 Tue Jul 01 04:31:02 EDT 2025 Sat Sep 06 07:35:31 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Multi-center clinical trial Poisson-gamma model Allocation randomness Recruitment time Maximum tolerated imbalance |
Language | English |
License | 2024. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c645t-1b4b4ac57c856bf72543d034cfb911baccb1d26ec84da7a7bddf1fa8cce9b6b13 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Undefined-1 ObjectType-Feature-3 content type line 23 |
ORCID | 0009-0004-6144-2344 0000-0002-7037-3641 0000-0001-6810-2845 0000-0003-2997-8566 0000-0002-1626-2588 0000-0003-1230-1794 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12874-023-02131-z |
PMID | 38418968 |
PQID | 2956865590 |
PQPubID | 42579 |
PageCount | 23 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_69347b89448b4b2a859933c3f412fa5c swepub_primary_oai_DiVA_org_uu_525900 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10900599 proquest_miscellaneous_2933462414 proquest_journals_2956865590 gale_infotracmisc_A784285996 gale_infotracacademiconefile_A784285996 pubmed_primary_38418968 crossref_primary_10_1186_s12874_023_02131_z crossref_citationtrail_10_1186_s12874_023_02131_z springer_journals_10_1186_s12874_023_02131_z |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-02-28 |
PublicationDateYYYYMMDD | 2024-02-28 |
PublicationDate_xml | – month: 02 year: 2024 text: 2024-02-28 day: 28 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | BMC medical research methodology |
PublicationTitleAbbrev | BMC Med Res Methodol |
PublicationTitleAlternate | BMC Med Res Methodol |
PublicationYear | 2024 |
Publisher | BioMed Central BioMed Central Ltd BMC |
Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: BMC |
References | W Zhao (2131_CR21) 2015; 41 2131_CR41 RD Hilgers (2131_CR6) 2017; 17 2131_CR42 D Blackwell (2131_CR44) 1957; 28 Y Ryeznik (2131_CR52) 2018; 37 SJ Pocock (2131_CR26) 1975; 31 WF Rosenberger (2131_CR46) 2008; 23 S Heritier (2131_CR24) 2005; 24 W Zhao (2131_CR20) 2014; 33 G Mijoule (2131_CR56) 2012; 31 J Lachin (2131_CR35) 1988; 9 2131_CR45 GF Borm (2131_CR40) 2005; 26 TM Therneau (2131_CR14) 1993; 14 YP Chen (2131_CR38) 2000; 32 A Hallstrom (2131_CR13) 1988; 9 DR Taves (2131_CR25) 1974; 15 2131_CR2 2131_CR1 2131_CR5 2131_CR7 M Zelen (2131_CR27) 1974; 27 AL Gould (2131_CR48) 1998; 17 2131_CR9 2131_CR15 2131_CR16 2131_CR17 VV Anisimov (2131_CR19) 2017; 36 2131_CR54 2131_CR11 DF Signorini (2131_CR23) 1993; 12 2131_CR12 VV Anisimov (2131_CR30) 2007; 26 JP Matts (2131_CR36) 1988; 9 HW Cai (2131_CR22) 2021; 106 R Chu (2131_CR50) 2011; 11 R Mountain (2131_CR55) 2022; 78 KD Barnard (2131_CR4) 2010; 10 2131_CR29 W Zhao (2131_CR39) 2011; 32 WF Rosenberger (2131_CR8) 2015 2131_CR28 M Morrissey (2131_CR57) 2010; 31 DJ McEntegart (2131_CR10) 2003; 37 2131_CR31 BC Kahan (2131_CR51) 2013; 32 VV Anisimov (2131_CR18) 2011; 10 O Sverdlov (2131_CR53) 2019; 38 S Senn (2131_CR3) 1998; 17 RM Pickering (2131_CR49) 2007; 26 2131_CR37 G Kundt (2131_CR43) 2009; 48 2131_CR32 2131_CR33 2131_CR34 B Jones (2131_CR47) 1998; 17 |
References_xml | – ident: 2131_CR28 doi: 10.1002/9780471462422.eoct301 – volume: 33 start-page: 5239 year: 2014 ident: 2131_CR20 publication-title: Stat Med doi: 10.1002/sim.6266 – ident: 2131_CR12 – volume: 31 start-page: 1655 issue: 16 year: 2012 ident: 2131_CR56 publication-title: Stat Med doi: 10.1002/sim.4495 – ident: 2131_CR37 doi: 10.1080/03610928308828586 – ident: 2131_CR42 doi: 10.1002/(SICI)1097-0258(19990730)18:14<1741::AID-SIM210>3.0.CO;2-F – volume: 23 start-page: 404 issue: 3 year: 2008 ident: 2131_CR46 publication-title: Stat Sci doi: 10.1214/08-STS269 – volume: 17 start-page: 1767 issue: 15–16 year: 1998 ident: 2131_CR47 publication-title: Stat Med doi: 10.1002/(SICI)1097-0258(19980815/30)17:15/16<1767::AID-SIM978>3.0.CO;2-H – volume: 78 start-page: 636 issue: 2 year: 2022 ident: 2131_CR55 publication-title: Biometrics doi: 10.1111/biom.13447 – volume: 17 start-page: 159 year: 2017 ident: 2131_CR6 publication-title: BMC Med Res Methodol. doi: 10.1186/s12874-017-0428-z – volume: 26 start-page: 4958 issue: 27 year: 2007 ident: 2131_CR30 publication-title: Stat Med doi: 10.1002/sim.2956 – ident: 2131_CR41 – volume: 26 start-page: 5445 issue: 30 year: 2007 ident: 2131_CR49 publication-title: Stat Med doi: 10.1002/sim.3068 – ident: 2131_CR16 doi: 10.1007/978-3-7908-2410-0_1 – volume: 32 start-page: 953 year: 2011 ident: 2131_CR39 publication-title: Contemp Clin Trials doi: 10.1016/j.cct.2011.08.004 – volume: 28 start-page: 449 issue: 2 year: 1957 ident: 2131_CR44 publication-title: Ann Math Stat doi: 10.1214/aoms/1177706973 – ident: 2131_CR32 – ident: 2131_CR45 doi: 10.1080/03610926.2022.2152286 – ident: 2131_CR17 doi: 10.1080/03610926.2011.581189 – volume: 24 start-page: 3729 year: 2005 ident: 2131_CR24 publication-title: Stat Med doi: 10.1002/sim.2421 – ident: 2131_CR15 – ident: 2131_CR29 doi: 10.1007/978-0-8176-4542-7_25 – ident: 2131_CR11 – volume: 31 start-page: 381 year: 2010 ident: 2131_CR57 publication-title: Contemp Clin Trials doi: 10.1016/j.cct/2010.05.002 – ident: 2131_CR33 doi: 10.1007/978-3-7908-1952-6_1 – ident: 2131_CR34 doi: 10.1007/978-3-030-48555-9 – ident: 2131_CR5 doi: 10.1016/j.cct.2015.11.008 – ident: 2131_CR1 doi: 10.1056/NEJM197607082950204 – volume: 106 year: 2021 ident: 2131_CR22 publication-title: Contemp Clinical Trials doi: 10.1016/j.cct.2021.106450 – volume: 32 start-page: 738 year: 2000 ident: 2131_CR38 publication-title: Adv Appl Probab doi: 10.1239/aap/1013540242 – volume: 17 start-page: 1753 issue: 15–16 year: 1998 ident: 2131_CR3 publication-title: Stat Med doi: 10.1002/(SICI)1097-0258(19980815/30)17:15/16<1753::AID-SIM977>3.0.CO;2-X – volume: 15 start-page: 443 issue: 5 year: 1974 ident: 2131_CR25 publication-title: Clin Pharmacol Ther doi: 10.1002/cpt1974155443 – volume: 11 start-page: 21 year: 2011 ident: 2131_CR50 publication-title: BMC Med Res Methodol doi: 10.1186/1471-2288-11-21 – volume: 17 start-page: 1779 issue: 15–16 year: 1998 ident: 2131_CR48 publication-title: Stat Med doi: 10.1002/(SICI)1097-0258(19980815/30)17:15/16<1779::AID-SIM979>3.0.CO;2-7 – volume-title: Randomization in Clinical Trials: Theory and Practice year: 2015 ident: 2131_CR8 – ident: 2131_CR9 – volume: 10 start-page: 50 issue: 1 year: 2011 ident: 2131_CR18 publication-title: Pharm Stat doi: 10.1002/pst.412 – volume: 12 start-page: 2343 issue: 24 year: 1993 ident: 2131_CR23 publication-title: Stat Med doi: 10.1002/sim.4780122410 – volume: 37 start-page: 3056 issue: 21 year: 2018 ident: 2131_CR52 publication-title: Stat Med doi: 10.1002/sim.7817 – volume: 32 start-page: 1136 issue: 7 year: 2013 ident: 2131_CR51 publication-title: Stat Med doi: 10.1002/sim.5667 – ident: 2131_CR2 – ident: 2131_CR7 doi: 10.1186/s12874-021-01303-z – volume: 36 start-page: 1302 issue: 8 year: 2017 ident: 2131_CR19 publication-title: Stat Med doi: 10.1002/sim.7206 – volume: 31 start-page: 103 issue: 1 year: 1975 ident: 2131_CR26 publication-title: Biometrics doi: 10.2307/2529712 – volume: 9 start-page: 312 year: 1988 ident: 2131_CR35 publication-title: Control Clin Trials doi: 10.1016/0197-2456(88)90046-3 – volume: 9 start-page: 375 issue: 4 year: 1988 ident: 2131_CR13 publication-title: Control Clin Trials doi: 10.1016/0197-2456(88)90050-5 – volume: 10 start-page: 63 year: 2010 ident: 2131_CR4 publication-title: BMC Med Res Methodol doi: 10.1186/1471-2288-10-63 – volume: 38 start-page: 2905 issue: 16 year: 2019 ident: 2131_CR53 publication-title: Stat Med doi: 10.1002/sim.8160 – ident: 2131_CR54 doi: 10.1016/j.cct.2015.07.010 – volume: 27 start-page: 365 year: 1974 ident: 2131_CR27 publication-title: J Chronic Dis doi: 10.1016/0021-9681(74)90015-0 – volume: 37 start-page: 293 year: 2003 ident: 2131_CR10 publication-title: Drug Inf J doi: 10.1177/009286150303700305 – volume: 9 start-page: 327 issue: 4 year: 1988 ident: 2131_CR36 publication-title: Control Clin Trials doi: 10.1016/0197-2456(88)90047-5 – volume: 26 start-page: 637 issue: 6 year: 2005 ident: 2131_CR40 publication-title: Contemp Clin Trials doi: 10.1016/j.cct.2005.09.002 – volume: 48 start-page: 129 issue: 2 year: 2009 ident: 2131_CR43 publication-title: Methods Inf Med doi: 10.3414/me0538 – ident: 2131_CR31 doi: 10.1007/978-3-031-17820-7_23 – volume: 14 start-page: 98 issue: 2 year: 1993 ident: 2131_CR14 publication-title: Control Clin Trials doi: 10.1016/0197-2456(93)90013-4 – volume: 41 start-page: 211 year: 2015 ident: 2131_CR21 publication-title: Contemp Clin Trials doi: 10.1016/j.cct.2015.01.013 |
SSID | ssj0017836 |
Score | 2.4197707 |
Snippet | Background
The design of a multi-center randomized controlled trial (RCT) involves multiple considerations, such as the choice of the sample size, the number... The design of a multi-center randomized controlled trial (RCT) involves multiple considerations, such as the choice of the sample size, the number of centers... Background The design of a multi-center randomized controlled trial (RCT) involves multiple considerations, such as the choice of the sample size, the number... BackgroundThe design of a multi-center randomized controlled trial (RCT) involves multiple considerations, such as the choice of the sample size, the number of... Background: The design of a multi-center randomized controlled trial (RCT) involves multiple considerations, such as the choice of the sample size, the number... Abstract Background The design of a multi-center randomized controlled trial (RCT) involves multiple considerations, such as the choice of the sample size, the... |
SourceID | doaj swepub pubmedcentral proquest gale pubmed crossref springer |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 52 |
SubjectTerms | Allocation randomness Clinical trials Design Evaluation Health Sciences Humans Information management Maximum tolerated imbalance Medical research Medicine Medicine & Public Health Medicine, Experimental Monte Carlo simulation Multi-center clinical trial Patient Selection Patients Poisson-gamma model Random Allocation Random variables Recruitment time Research Design Research methodology Sample Size Statistical Theory and Methods Statistics for Life Sciences Theory of Medicine/Bioethics |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gL4k2gICOBOEDUTfyIfVweVYVULlDUm-WnuhLNou3m0l_PjJ0sTZHKhUNyiJ2Hx-N5xDPfEPJag0_gLVYviw5OKsXaKaFqF8C-CFEwnR3F46_y6IR_ORWnV0p9YUxYgQcuhDuQmvHOKQ1uhOOutUqARmWeJd60yQqP0nehF5MzNe4fYG7ClCKj5MFFg7DuNegnOBrW1JczNZTR-v-WyVeU0vWAyd2u6TWE0ayVDu-Ru6M5SZdlGPfJrdg_ILePxw3zh-T8W65zAw-hloJaCuvzMfGSltrRFIxWaMpxhTW-OG7olC1Jc0kPir9qKdiI_swiqDMFGbkZVjk6nfqx3mf57_eInBx-_v7xqB4rLNRecrGtGyApt150XgnpUoeZ8WHBuE8OhKCz3rsmtDJ6xYPtbOdCSE2yyvuonXQNe0z2-nUfnxKahE4peCEiupi4m9hZa3Ub4PkIQVORZiK48SP8OFbB-GmyG6KkKZNkYJJMniRzWZF3u3t-FfCNG3t_wHnc9UTg7HwB2MmM7GT-xU4VeYtcYHB5w-d5O2YpwCARKMssO8UR80_LiuzPesKy9PPmiY_MKBYuTIvJmRKcuEVFXu2a8U4MdevjesA-jHEJhhWvyJPCdrshMcUbpSUQU80YcjbmeUu_Osug4RiAi1g8FXk_8e6f77qJqG8Kf89e8Wn1Y5nJOgxGtFh49tn_IP5zcqcFm7EgBuyTve1miC_A5tu6l3l5_wZnllOq priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSIgL4k2gICOBOEDUOrEd54SWR1UhlQsU7c3yK3QlmpTdzaW_nhnHSUmR9rA5rJ3H2ON52DPfEPK6Bp_AGaxeFixcVBNyq4TKrQf7wgdR1tFRPPkmj0_516VYpg23TQqrHGViFNS-c7hHflBgXpsE-_fww8WfHKtG4elqKqFxk9yK0GXAz9VycrgYZiiMiTJKHmwYgrvnoKXgx0qWX86UUcTs_18y_6OarodNTmen13BGo246ukfuJqOSLgYuuE9uhPYBuX2Sjs0fkvPvsdoNPIQaCsrJd-cp_ZIOFaQpmK7QFKMLc3xxWNMxZ5LGwh4UN2wpWIruzCC0MwVJue5XMUadulT1c9j9e0ROj778-HScpzoLuZNcbHNmueXGicopIW1TYX68Pyy5ayyIQmucs8wXMjjFvalMZb1vWGOUc6G20rLyMdlruzY8JbQRddN4J0RARxPPFCtjTF14eD4C0WSEjQOuXQIhx1oYv3V0RpTUwyRpmCQdJ0lfZuTddM_FAMGxs_dHnMepJ8Jnxz-69S-dVqOWdckrq2rwTYH2wigBZlrpyoazojHCZeQtcoHGRQ6f50zKVQAiES5LLyrFEfmvlhnZn_WExenmzSMf6SQcNvqKlTPyamrGOzHgrQ1dj33Kkkswr3hGngxsN5FUKs5ULWEw1YwhZzTPW9rVWYQOxzBcROTJyPuRd6--a9egvhn4e_aKz6ufizisfa9FgeVnn-0m9zm5U4BNOCAC7JO97boPL8Cm29qXceH-BTcZTCw priority: 102 providerName: ProQuest – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELagSIgL4k2gICOBOEBEHT_iHJdCVSGVCxT1ZvmprkR30XZz6a9nxnFCU1AlDskhfiT2jD0zGc83hLzuwCbwFrOXRQc3nWLttNS1C6BfhCh5lw3Fo6_q8Fh8OZEnBSYHY2Eu---ZVh_OGQKy1yBZ4GKc1Rc3yS3JuMqOWbU_eQwwGmEMivlnu5ngyfj8f-_Cl8TQ1SOSk5_0CqZolkMH98jdokDSxUDx--RGXD0gt4-Ki_whOfuWM9tAJ9RSEERhfVZCLemQLZqCmgpF-SRhjS-OGzrGR9KcxIPiz1kKWqE_tQjjTGFX3PTLfB6d-pLhc_jT94gcH3z-vn9Yl5wKtVdCbmvmhBPWy9ZrqVxqMRY-7HHhk4Ntz1nvHQuNil6LYFvbuhASS1Z7HzunHOOPyc5qvYpPCU2ySyl4KSMaleg_bK21XROgfwSdqQgbJ9z4AjiOeS9-mmx4aGUGIhkgkslEMhcVeTe1-TXAbVxb-yPScaqJUNn5AXCQKSvPqI6L1ukO7FAYe2O1BJWMe54Ea5KVviJvkQsMLmj4PG9LXAIMEqGxzKLVAlH-OlWR3VlNWIh-XjzykSkbwblpMBxTgdm2V5FXUzG2xMNtq7jusQ7nQoEqJSryZGC7aUhcC6Y7BZOpZww5G_O8ZLU8zTDheOQW0Xcq8n7k3T_fdd2kvhn4e_aKT8sfizytfW9kg6lmn_1ft8_JnQb0wQENYJfsbDd9fAH63Na9zAv5N9QBRWo priority: 102 providerName: Springer Nature |
Title | Selecting a randomization method for a multi-center clinical trial with stochastic recruitment considerations |
URI | https://link.springer.com/article/10.1186/s12874-023-02131-z https://www.ncbi.nlm.nih.gov/pubmed/38418968 https://www.proquest.com/docview/2956865590 https://www.proquest.com/docview/2933462414 https://pubmed.ncbi.nlm.nih.gov/PMC10900599 https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-525900 https://doaj.org/article/69347b89448b4b2a859933c3f412fa5c |
Volume | 24 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwED_tQ0K8IL4JjMpIIB4gbE5sx3lAqC2bJqROaFBU8WLZTsIqbS10rQT767lzko6MaQ-N1Nhx4vPZd2ff_Q7gZY42gbeUvax0eNFVGTstdewK1C-KUqZ5MBRHR-pwLD5N5GQD2nRHDQHPrzXtKJ_UeHH67vevPx9wwr8PE16r3XNOoO0xSh_88ZTHF5uwjZJJkTE2EpenChSxEKKNMh4nidZtEM21bXQEVcDz_3_V_kdsXXWpXJ-rXsEgDXLr4C7caRRO1q855B5slLP7cGvUHKk_gLMvIRMONsIsQ8FVzM-a0ExWZ5dmqNZiUfA8jOnF5YK18ZQsJP1gtJnLUIv0J5ZgnxmuoovVNPivM99kBK13Bh_C-GD_6_AwbnIwxF4JuYy5E05YLzOvpXJVRrHzxV4qfOVwmXTWe8eLRJVei8JmNnNFUfHKau_L3CnH00ewNZvPyifAKplXVeGlLMkIpfPGzFqbJwW2TyA1EfCW4MY3AOWUJ-PUBENFK1MPksFBMmGQzEUEb9bP_KzhOW6sPaBxXNckaO1wY774YZqZalSeiszpHO1W7HtitUQVLvVpJXhSWekjeE1cYIgl8fO8beIYsJMEpWX6mRaECpirCHY6NXHi-m5xy0em5XuTUPimQjNvL4IX62J6kpzhZuV8RXXSVChkcBHB45rt1l1KteA6V0hM3WHITp-7JbPpSYAVJxddQuuJ4G3Lu5ffdRNRX9X83XnFx-m3fiDramVkQqlpn95MjWdwO0F9sUYL2IGt5WJVPkd9b-l6sJlNsh5sD_aPPh_jv6Ea9sLeSS9Mb7weD77_BfmkVos |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELbKVgIuiDeBAkai4gBRm8R2nANCW9pqS7srBG3Vm7Edh65Es2UfQvRH8RuZcR4lRdpbD5vD2nnYM56HPfMNIa8z8AmsxuplzsBFFi40ksvQ5GBf5I4nmXcUhyMxOGKfTvjJCvnT5MJgWGUjE72gzicW98g3YsxrE2D_bn44_xli1Sg8XW1KaFRsse9-_wKXbfZ-bxvoux7HuzuHHwdhXVUgtILxeRgZZpi2PLWSC1OkmA2ebybMFgYWvtHWmiiPhbOS5TrVqcnzIiq0tNZlRpgogefeIKsMM1p7ZHVrZ_T5S3tugTkRTWqOFBuzCOHkQ9CL8IuSKLzoqD9fJeB_XfCPMrwaqNme1l5BNvXacPcuuVObsbRf8d09suLK--TmsD6of0DOvvr6OvAQqimow3xyVid80qpmNQVjGZp8PGOIL3ZT2mRpUl9KhOIWMQXb1J5qBJOmIJuni7GPiqe2rjNa7Tc-JEfXQoNHpFdOSveE0IJnRZFbzh26tniKmWqtsziH5yP0TUCiZsKVrWHPsfrGD-XdHylURSQFRFKeSOoiIG_be84r0I-lvbeQjm1PBOz2f0ym31W9_pXIEpYamYE3DGOPteRgGCY2KVgUF5rbgLxBLlAoVuDzrK6zI2CQCNCl-qlkiDWYiYCsdXqCOLDd5oaPVC2OZupy8QTkVduMd2KIXekmC-yTJEyAQccC8rhiu3ZIiWSRzARMpuwwZGfM3ZZyfOrByjHwFzGAAvKu4d3L71o2qesVf3desT0-7vtpXSwUj7Hg7dPlw31Jbg0OhwfqYG-0_4zcjsEirfAI1khvPl2452BRzs2LehlT8u26JcdfpLeNfQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELagSBUXVJ4NLWAkEAeIWie24xyXllV5tEKCot4sP-lKNFttdy_99cw4D5qCKnFIDvEjsT32zGRmviHkVQ06gTOYvSxYuKkYcquEyq0H-cIHUdZJUTw8kgfH_NOJOLkSxZ-83XuTZBvTgChNzXLn3Md2iyu5c8EQpj0HfgMXK1l-eZvc4cj60Fwr9wY7AsYo9KEy_2w3YkcJtf_vs_kKc7ruODlYT68hjSbuNN0g9zqxkk5aOrhPboXmAVk_7AznD8nZt5TvBjqhhgJ78vOzLgCTtjmkKQivUJT8C3N8cVjQPmqSptQeFH_ZUpAV3alBcGcKZ-ViNUte6tR1eT_b_3-PyPH0w_e9g7zLtJA7ycUyZ5ZbbpyonBLSxgoj5P1uyV20cBha45xlvpDBKe5NZSrrfWTRKOdCbaVl5WOy1sybsEloFHWM3gkRUNVEq2JljKkLD_0jFE1GWD_h2nUw5JgN45dO6oiSul0kDYuk0yLpy4y8HdqctyAcN9Z-j-s41EQA7fRgvvipu_2oZV3yyqoatFMYe2GUAEGtdGXkrIhGuIy8QSrQuM3h85zpohVgkAiYpSeV4oj9V8uMbI9qwvZ04-KejnR3PFzoAoM0JShzuxl5ORRjS3R5a8J8hXXKkksQsHhGnrRkNwypVJypWsJkqhFBjsY8Lmlmpwk8HB1xEZMnI-962v3zXTdN6uuWvkev2J_9mKRpXa20KDAB7dP_6_YFWf-6P9VfPh593iJ3CxAYW7iAbbK2XKzCMxD4lvZ52tO_AV1fUJ4 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Selecting+a+randomization+method+for+a+multi-center+clinical+trial+with+stochastic+recruitment+considerations&rft.jtitle=BMC+medical+research+methodology&rft.au=Sverdlov%2C+Oleksandr&rft.au=Ryeznik%2C+Yevgen&rft.au=Anisimov%2C+Volodymyr&rft.au=Kuznetsova%2C+Olga+M&rft.date=2024-02-28&rft.pub=BioMed+Central+Ltd&rft.issn=1471-2288&rft.eissn=1471-2288&rft.volume=24&rft.issue=1&rft_id=info:doi/10.1186%2Fs12874-023-02131-z&rft.externalDocID=A784285996 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2288&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2288&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2288&client=summon |